In the latest trading session, 17.06 million Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) shares changed hands as the company’s beta touched 1.41. With the company’s most recent per share price at $0.20 changed hands at -$0.04 or -15.50% at last look, the market valuation stands at $3.89M. SNOA’s current price is a discount, trading about -410.0% off its 52-week high of $1.02. The share price had its 52-week low at $0.12, which suggests the last value was 40.0% up since then. When we look at Sonoma Pharmaceuticals Inc.’s average trading volume, we note the 10-day average is 0.74 million shares, with the 3-month average coming to 4.68 million.
Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) trade information
Instantly SNOA was in red as seen in intraday trades today. With action -13.06%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 13.64%, with the 5-day performance at -13.06% in the red. However, in the 30-day time frame, Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) is -45.30% down. Looking at the short shares, we see there were 0.7 million shares sold at short interest cover period of 0.18 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sonoma Pharmaceuticals Inc. (SNOA) estimates and forecasts
Data shows that the Sonoma Pharmaceuticals Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 32.77% over the past 6 months, a 47.37% in annual growth rate that is considerably higher than the industry average of 19.50%. Year-over-year growth is forecast to reach 33.30% up from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 3.98M. 1 analysts are of the opinion that Sonoma Pharmaceuticals Inc.’s revenue for the current quarter will be 4.39M.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 47.04%. The 2024 estimates are for Sonoma Pharmaceuticals Inc. earnings to increase by 55.81%.
SNOA Dividends
Sonoma Pharmaceuticals Inc. is expected to release its next quarterly earnings report on 2024-Nov-11.
Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.11% of Sonoma Pharmaceuticals Inc. shares while 2.29% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.34%. There are 2.29% institutions holding the Sonoma Pharmaceuticals Inc. stock share, with CITADEL ADVISORS LLC the top institutional holder. As of 2024-06-30, the company held 1.2504% of the shares, roughly 0.2 million SNOA shares worth $41412.0.
GEODE CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 0.5551% or 86644.0 shares worth $18385.0 as of 2024-06-30.
